CODE formulas have gone through extensive evaluation, and many have undergone clinical studies. CODE Health has partnered with Beech Tree Labs and holds licensing to molecular formulas invented by Dr. John McMichael. CODE Health obtained these formulas to develop over-the-counter products safe for people and animals.

For those seriously interested in the scientific details of our products, please feel free to request the lengthy research that was conducted and required in order to obtain patents.

The following are just a few of the research articles that have been published.

Recover

Mathews, M., Bernstein, R. Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity. Nature 304, 177–179 (1983). https://doi.org/10.1038/304177a0

Miller FW, Love LA, Barbieri SA, Balow JE, Plotz PH. Lymphocyte activation markers in idiopathic myositis: changes with disease activity and differences among clinical and autoantibody subgroups. Clin Exp Immunol. 1990 Sep;81(3):373-9. doi: 10.1111/j.1365-2249.1990.tb05341.x. PMID: 2168821; PMCID: PMC1534997.

Breathe

Stephen Mamber, John McMichael, 2006. Microdose DNA for the Treatment of Acute and Chronic Respiratory Diseases and Otitis Media. The Journal of the American Nutraceutical Association, Vol. 9, No. 1, 13-22. https://beechtreelabs.com/wpcontent/uploads/2022/07/Microdose_DNA_for_the_treatment.pdf McMichael.

Antivirus

Visit clinicaltrials.gov, the U.S. National Library of Medicine database of clinical studies conducted around the world. ClinicalTrials.gov identifier (NCT number): NCT04522830

Mamber SW, Hatch T, Miller CS, et al., 2022. Low-dose Oral Thimerosal for the Treatment of Oral Herpes: Clinical Trial Results and Improved Outcome After Post-hoc Analysis of Evidence-based Integrative Medicine. Jan-Dec; 27:2515690X221078004. DOI: 10.1177/2515690×221078004. PMID: 35142535; PMCID: PMC8841908.

Stephen W Mamber, Steven Krakowka, Jeffrey Osborn, Lloyd Saberski, Ryan G Rhodes, Albert E Dahlberg, Sunthorn Pond-Tor, Kara Fitzgerald, Neal Wright, Sarah Beseme, John McMichael, 2020. Can Unconventional Immunomodulatory Agents Help Alleviate COVID-19 Symptoms and Severity? May 13; 5(3):e00288-20. doi: 10.1128/mSphere.00288-2

React

Sue C. Killian, MS, with John McMichael, PhD. Indianapolis: Xlibris, 2017. Allergy and Cross-Reactivity. (book).

Sue Killian and John McMichael.2015. Allergy Induced Back Pain: A Report of Two Cases of Allergy Disorders and Therapy, Vol. 2, Issue 1, 1-4.

Calm

John E. McGeary, Volkan Gurel, Valerie S. Knopik, JamesSpaulding, JohnMcMichael, 2011. Effects of nerve growth factor (NGF), fluoxetine, and amitriptyline on gene expression profiles in rat brain. Neuropeptides, 45(5): 317-22. doi:10.1016/j.npep.2011.06.002

David H. Overstreet, Kellie Fredericks, Darin Knapp, George Breese, John McMichael, 2010. Nerve growth factor (NGF) has novel antidepressant-like properties in rats. Pharmacol Biochem Behav. Feb; 94(4): 553–560. doi: 10.1016/j.pbb.2009.11.010

Protect

Bonnie Rush Moor, Steven Krakowka, Joseph M. Cummins, James T. Robertson, Changes in airway inflammatory cell populations in Standardbred racehorses after interferon-alpha administration. Veterinary Immunology and Immunopathology, Volume 49, Issue 4, 1996, Pages 347-358, ISSN 0165-2427, https://doi.org/10.1016/0165-2427(95)05480-4. (https://www.sciencedirect.com/science/article/pii/0165242795054804)

Weiss, R & Cummins, Joseph & Richards, Alan. (1991). Low-dose orally administered alpha interferon treatment for feline leukemia virus infection. Journal of the American Veterinary Medical Association. 199. 1477-81.

Bennett, Alayne & Smith, David & Cummins, Martin & Jacoby, Peter & Cummins, Joseph & Beilharz, Manfred. (2013). Low-dose oral interferon alpha as prophylaxis against viral respiratory illness: A double-blind, parallel controlled trial during an influenza pandemic year. Influenza and other respiratory viruses. 7. 10.1111/irv.12094.

CODE Health Research on CALM (Healthy Mind Formula) Using the Bio-Well GDV Device

Method: 26 Participants were given a consultation questionnaire before taking a stress scan using the Bio-Well GDV device. After the scan, 1 drop of CALM (Healthy Mind Formula) was administered under the participant’s tongue. A timer was set for 15 minutes. A second stress scan was taken, and in some cases, the timer was set for another 15 minutes, followed by a third stress scan at the 30 minute mark.

  • Out of 26 Participants, 21 had higher than optimal stress energy.
  • Results varied based on the individual.
  • Objective findings showed 86% had a decrease in stress energy by the 30-minute mark.
  • 72% Perceived a decrease in the feeling of stress.
  • Subjective Perception- people are accustomed to a stressful lifestyle and many could not discern when their stress was high, let alone when it decreased. They were also unclear of the difference between stress and anxiety.
  • Significance- How much did the stress decrease, and did that contribute to the perception of less stress?

Bio-Well Saline Comparison

Water Sensor Testing confirms that there is a difference between normal saline solution and the bioenergetically infused saline solution in CALM.

Orange- Normal Saline Solution

Purple- CALM, Bioenergetic Formula

Findings of Saline Analysis

  • Area Energy is Higher
  • Intensity is Higher
  • Area Deviation is Higher
  • Entropy is lower, proving CALM is more coherent.